HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hb Geelong [beta 139(H17)Asn----Asp].

Abstract
Hb Geelong [beta 139(H17)Asn----Asp] was detected in a German woman of Polish-Russian descent. It is an unstable variant which appears to increase the severity of a beta (+)-thalassemic phenotype in the propositus. The electrophoretic properties of Hb A and Hb Geelong are similar on cellulose acetate in both acidic and alkaline conditioning. The electrophoretic mobility and the amino acid analysis of beta XT-14 indicated the substitution Asn----Asp at beta 139. The sequence of beta XT-14 was confirmed by dansyl-Edman degradation. The slight increase observed in the P50 of whole blood is not intrinsic to the beta 139 substitution, but is thought to result from an increased 2,3-diphosphoglycerate level in response to anemia. No family studies were possible to investigate the mode of inheritance of either beta (+)-thalassemia or Hb Geelong in the propositus. Synthetic globin chain ratios suggest that impaired synthesis of the variant globin chain is partially responsible for the low level of Hb Geelong in peripheral blood.
AuthorsP F Como, D R Hocking, G W Swinton, R J Trent, R A Holland, E A Tibben, T Wilkinson, H Kronenberg
JournalHemoglobin (Hemoglobin) Vol. 15 Issue 1-2 Pg. 85-95 ( 1991) ISSN: 0363-0269 [Print] England
PMID1917539 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Diphosphoglyceric Acids
  • Hemoglobins, Abnormal
  • hemoglobin Geelong
  • 2,3-Diphosphoglycerate
  • Globins
  • Oxygen
Topics
  • 2,3-Diphosphoglycerate
  • Adult
  • Amino Acid Sequence
  • Diphosphoglyceric Acids (blood)
  • Female
  • Globins (genetics)
  • Hemoglobinopathies (blood, complications, genetics)
  • Hemoglobins, Abnormal (chemistry, genetics)
  • Humans
  • Molecular Sequence Data
  • Oxygen (metabolism)
  • Phenotype
  • Thalassemia (blood, complications, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: